Abstract To improve the safety of the use of a power injector for pediatric contrast CT, we newly developed a saline test injection mode for a power injector and investigated its usefulness. We used an injection route and investigated the relationship of the injection pressure to the injection rate of saline and the contrast medium. From this relationship, we investigated it was possible to estimate the change of pressure injection of contrast medium from the pressure change of saline injection. The correlation between the saline test injection pressure and the contrast medium injection pressure was investigated in 64 clinical cases. The detection rate of side effects from the saline test injection was investigated in 473 patients. Regarding the correlation between the injection rate and pressure for both saline and contrast, the pressure rose as the rate increased. The contrast medium injection pressure could be estimated from the correlation observed with saline. The clinical data were obtained had a relationship similar to that with phantom data. The detection rate of side effects from the saline test injection was 4.4 % in the clinical cases. In these cases, examinations were completed by re-establishing an injection route or administering hypnotics. Our results suggest that contrast medium pressure can be estimated from a saline test injection, thus aiding in prediction of the risk of injection abnormality. Reactions to injections could be observed in the present study, facilitating the prevention of examination failure. Countermeasures can be taken against the cause of the reaction, and the examination can be performed after confirming the absence of a reaction to injection. Therefore, a saline test injection may be useful in pediatric contrast CT.
Introduction
Technological advances in multi-detector computed tomography (MDCT) have facilitated the acquisition of long, high resolution images within short periods of time. These advances also contribute to cardiovascular computed tomography angiography (CTA), and in some cases, multiphase imaging of tumors using pediatric computed tomography (CT) [1] , which plays an important role in diagnosis. The use of a power injector in this examination is beneficial because it decreases variability caused by the conditions under which the injections are administered [2] . However, the use of an injector is avoided in many pediatric patients because of a high risk of extravasation of contrast medium from blood vessels much smaller than adults. [3] .
In our pediatric hospital, we use a power injector for most cases requiring contrast-enhanced CT. In patients undergoing contrast-enhanced CT, the injection route is confirmed beforehand with a drip injection of 10-20 mL/h of saline and the absence of malfunction or abnormalities is confirmed at the time of examination. In addition, when the contrast medium injection route is connected, 1-3 mL of saline is slowly and manually injected, and the absence of abnormal resistance or reaction to stimulation is confirmed. We encountered contrast medium extravasation and body movement in response to stimulation from injection even after employing this procedure, resulting in failure of the examination. We hypothesized that if injection-induced abnormalities can be identified before contrast medium injection, the examination failures can be prevented and safety can be improved.
Therefore, we installed a saline test injection mode, which allows the adjustment of the injection mode of a power injector to a specific rate and volume, and makes it possible to inject an amount of saline equivalent to that of contrast medium. Regarding the risk of extravasation, it has been reported that there was no correlation between injection rate and extravasation rate or comprehensive reactions [4] [5] [6] [7] [8] . However, Amaral et al. [2] reported that extravasation was related to a high injection rate and pressure, regardless of the location, size, or type of catheter, and that the risk of extravasation increased as pressure rose. Therefore, the risk of extravasation may be predicted on the basis of injection pressure. In many pediatric cases, since the examination is performed while the patient is sedated, abnormalities associated with contrast medium injection are not readily noticed. Changes in injection pressure serve as a clue to abnormalities. Based on these reasons, we designed the saline test injection mode to be able to confirm pressure changes on a graph and in reported values.
In this study, we investigated whether it was possible to estimate pressure changes during the injection of contrast medium from pressure changes during the injection of saline. Further, we investigated the usefulness of the saline test injection mode for detecting an abnormal injection and whether stimulation by saline injection helped to avoid failure.
Materials and methods
We installed a saline test injection mode, which allows for adjustment of a power injector's injection mode to a specific rate and volume. Injection pressure was defined as the equilibrium pressure displayed on the power injector monitor.
We investigated the relationship between the saline injection pressure and that of contrast media in a phantom model and determined the possibility of predicting the injection pressure of contrast media on the basis of the injection pressure of saline. We also investigated the relationship between the injection pressure of saline and that of contrast media in actual clinical cases. The detection rate of side-effects from the saline test injection was also determined.
Saline test injection mode
The saline test injection mode involves the injection of saline at an optional rate and volume. Changes in pressure can be confirmed by the pressure curve graph and reported values. Figure 1 shows a schematic diagram of the characteristic changes in pressure caused by the contrast agent injection. When the contrast medium injection is normal, the pressure rises from the state of injection initiation and reaches equilibrium (Fig. 1a) . However, when an abnormality occurs, the pressure rises to an abnormally high level (Fig. 1b) , or suddenly decreases (Fig. 1c) . Sometimes, it continues to rise and does not become constant (Fig. 1d) . Therefore, injection related abnormalities can be detected by monitoring changes in the pressure curve.
Correlations between saline and contrast media injection pressures in a phantom model All injection tests were conducted using a power injector (DUALSHOT TypeG: Nemoto Kyorindo Co. Ltd. Tokyo, Japan). Saline injection was performed using the saline test injection mode.
To investigate the relationship between the injection pressures of saline and contrast medium in the phantom model, we used a phantom system that comprised of a power injector and a dual purpose extension tube (Nemoto Kyorindo Co. Ltd. Tokyo, Japan). We routinely used a contrast medium injection route and an 18-gauge angiocatheter. (Becton, Dickinson and Company Franklin Lakes, USA). We measured the injection pressures of saline and contrast medium while varying the injection rate. From these results, in addition to determining the possibility of predicting contrast medium injection pressure from saline injection pressure, the correlation between the pressures of saline and contrast medium was evaluated.
The pressure displayed on the power injector is the force pressing on the syringe, not the pressure generated in the actual blood vessels. To estimate the correlation between injection pressures generated by different syringes and intravascular pressure, we used an extention tube (TOP Corporation Tokyo, JAPAN) as a blood vessel, and measured the intra-tube pressure with a bedside monitor (DYNASCOPE DS-7111, FUKUDA DENSHI Tokyo, Japan) (Fig. 2 ).
Our hospital treats neonates as well as patients with physiques equivalent to adults. Therefore, we determine which type of syringe and contrast medium to use depending on the physique of the patient and the examination results. For cardiovascular CTA in patients weighing 10 kg, we injected an upper limit of 4 mL/kg of contrast media of 150 mgI/mL concentrations. For cardiovascular CTA in patients weighing [10 kg except in patients requiring cardiovascular procedures, we injected an upper limit of 2 mL/kg of contrast medium of 300 mg/ mL concentration. When the volume of injection was 25 mL, we used a 30 mL syringe. A 100 mL syringe was used for patients requiring further examination. The examination was performed using the same kind of syringes and contrast media used in routine examinations.
Contrast medium was administered using a 100 mL disposable syringe (Nemoto disposable syringe, 100 mL) and a 30 mL disposable syringe (Terumo syringe 30 mL), whereas saline was administered using a 50 mL disposable syringe (Nemoto disposable syringe 50 mL). For contrast media, a syringe preparation of 300 mgI/mL (Oypalomin 300 Inj) and vial preparations of 300 mgI/mL (Oypalomin 300 Inj) and 150 mgI/mL (Oypalomin 150 Inj) were used.
Contrast medium and saline were injected at rates of 0.5-3.5 mL/s (in increments of 0.5 mL/s). Comparisons with clinical data
We recorded the infusion pressures of saline test and contrast media injections administered to patients between July 16, 2011 and September 30, 2011. A total of 64 patients (34 boys and 30 girls) aged 0-15 years (mean age, 3.41 years) were included in the study. Table 1 shows the syringes, contrast media, and injection rates used. The infusion needle used was a 22 or 24-gauge angiocatheter. The correlation between the saline test injection pressure and contrast medium injection pressure was investigated in the clinical cases. The injection pressure was defined as the pressure at an equilibrium state on the power injector monitor. The contrast media were warmed to approximately 37°C.
Detection rate of side effects from the saline test injection
The detection rate of side effects from the saline test injection was investigated in 473 patients (249 boys and 224 girls) aged 0-15 years (mean age, 3.14 years) who underwent contrast CT between April 1,2011 and January 31,2012.
When extravasation occurs as a side effect of the saline test injection, there are changes in the infusion pressure graph, as shown in (Fig. 1b, c, d ). When we saw a change that was different from normal, it was assumed that body movement occurred from the stimulation of the injection. The saline test injection was used when no extravasation, no abnormal resistance and no reaction to stimulation were noted during a slow manual preliminary injection of 1-3 mL saline.
The injection rate of the saline test injection was the same as the contrast medium injection.
Results
Correlations between saline injection and contrast medium injection pressures in the phantom model Figure 3a shows the injection rate of the saline and the associated injection pressure, the correlation between the injection rate (x) and pressure (y) was y = 0.789x (r = 0.958). Figure 3b shows the injection rate of the contrast medium and the associated injection pressure; the correlation between the injection rate (x) and pressure (y) for a 300 mgI/mL syringe preparation, 300 mgI/mL of contrast medium in a 30 mL disposable syringe, 150 mgI/ mL of contrast medium in the 100 mL disposable syringe, and 150 mgI/mL of contrast medium in the 30 mL disposable syringe were y = 1.533x (r = 0.989), y = 1.271x (r = 0.976), y = 0.867x (r = 0.974), and y = 0.633x (r = 0.968), respectively. These results indicate that the pressure increased with an increase in the injection rate. In addition, the injection pressure of the contrast medium increased with increases in concentration and volume. Figure 4 shows the relationship between contrast medium injection pressure, which was calculated using the above relationships, and saline injection pressure. The correlation between saline injection pressure (x) and contrast medium injection pressure (y) were y = 1.922x for the 300 mgI/mL syringe preparation, y = 1.593x for 300 mgI/mL preparation in the 30 mL disposable syringe, y = 1.086x for 150 mgI/mL preparation in the 100 mL disposable syringe, and y = 0.794x for 150 mgI/mL preparation in the 30 mL disposable syringe. Figure 5 shows the injection tube pressure at different injection rates, measured using a bedside monitor. The correlations between the injection rate (x) and intra-tube pressure (y) were y = 239.00x (r = 0.997) for the 300 mgI/mL syringe preparation, y = 238.21x (r = 0 .999) for 300 mgI/mL preparation in the 30 mL disposable syringe, y = 106.73x (r = 0.987) for 150 mgI/mL preparation in the 100 mL disposable syringe and y = 106.24x (r = 0.983) for 150 mgI/mL preparation in the 30 mL disposable syringe.
Correlations between the intra-tube pressure and injection rate of contrast medium at equivalent concentrations were similar, regardless of the syringe type. Table 1 The syringes, contrast media, and injection rates used Rate(mL/s) 30 mL syringe 100 mL syringe 150 mgI/mL 300 mgI/mL 150 mgI/mL 300 mgI/mL 0. Comparisons with clinical data Figure 6 presents the clinical data used to determine the relationship between contrast medium injection pressure and saline injection pressure. The correlations between saline injection pressure and contrast medium injection pressure for the respective clinical data were y = 2.397x (r = 0.917) for the 300 mgI/mL syringe preparation, y = 1.500x (r = 0.914) for 300 mgI/mL preparation in the 30 mL disposable syringe, y = 1.255x (r = 0.977) for 150 mgI/mL preparation in the 100 mL disposable syringe, and y = 0.888x (r = 0.951) for 150 mgI/mL preparation in the 30 mL disposable syringe.The correlation between saline injection pressure and contrast medium injection pressure is a gentle incline for the 300 mgI/mL preparation in the 30 mL disposable syringe, and a sharp incline for all other preparations when compared with the phantom data.
Detection rate of side effects from the saline test injection Table 2 shows the detection rate of side effects from the saline test injection. Side effects were detected in 21 (4.4 %) out of 473, extravasation in 5 (1.1 %), high pressure in 7 (1.5 %), and stimulation in 9 (1.9 %). Examinations were successfully completed by re-establishing an injection route and adding hypnotics in 19 of 21 patients. Two patients did not show high pressure or body movement during the saline test injection, and we judged that there were no injection abnormalities and injected contrast medium. However, the patients showed a stimulation response from the contrast medium injection, and the examinations failed as a result.
Discussion
To improve the safety of the use of a power injector with pediatric contrast CT, we developed a saline test injection mode for a power injector and investigated its value. We determined that contrast medium injection pressure could be estimated from the saline test injection pressure. Moreover, reactions to the injection could also be observed, facilitating the prevention of examination failure. Contrast medium injection-induced abnormalities could be detected with the use of a saline test injection in which saline, which has lower toxicity [7] and pressure than contrast media, was injected, suggesting the value of a saline test injection mode to increase the safety of pediatric contrast CT procedures utilizing a power injector.
With regard to the correlation between the injection rate and injection pressure for saline and contrast medium in the phantom model, the pressure increased with an increase in the injection rate, similar to findings reported by Ruess et al. [8] . The change in contrast medium injection pressure could be estimated from the relationship between the contrast medium injection pressure and the saline injection pressure. With regard to the relationship between the contrast medium concentration and injection pressure, the pressure increased as the concentration increased. We infer that the high viscosity of high concentration contrast medium influenced this finding. Regarding the correlation between syringe type and injection pressure, when using the same contrast medium, the displayed pressure was lower when a smaller syringe was used. However, the intra-tube pressure of the bedside monitor was similar when the contrast medium concentration was the same, regardless of syringe type. This result suggests that the difference between the pressure displayed on the injector and the intra-tube pressure was a result of the syringe gasket area. Because the power injector pressure represents the force pressing on the syringe, the injection rate can be increased by adding a small force when the gasket size is small. However, the same volume is injected into the tube at the same rate regardless of size, generating the same intra-tube pressure. Accordingly, to change the injector pressure when using several syringes, a pressure limit should be established corresponding to the syringe type.
The pressure correlation in the clinical cases was similar to that in the phantom model. While the value for the 150 mgI/mL preparation in clinical cases was similar to that in the phantom model, the value for the 300 mgI/mL preparation in clinical cases was higher than that in the phantom model. When high concentration contrast medium is injected into the circulating blood of a living body, the resistance in the blood vessel can be estimated with a comparison of the resistance in the phantom model. That is, the danger posed by high concentrations of contrast media is revealed. The saline test injection can be used to estimate the high injection pressure of the contrast medium from a the low injection pressure of the saline.
For a 30 mL syringe, the clinical injection data showed lower pressure compared with the phantom data. Because the clinical data were obtained from a small number of cases, further examination is necessary.
The procedure for the saline test injection is as follows. The contrast medium injection route was connected, approximately 1-3 mL of saline was injected slowly and manually, and the absence of abnormal resistance or reaction to stimulation was confirmed. At this point, if extravasation was detected, we used another injection route. If there was no extravasation, but only a reaction upon stimulation, the strength of the sedation was increased to reduce movement. If no additional malfunctions occurred during manual injection, the saline test injection was performed. In both the saline test injection and the manual injection, the same measures were taken to detect stimulation and extravasation. If high pressure is detected during the saline test injection check the injection pressure. If the risk of extravasation from contrast media injection is high, adjust the injection rate or secure another route. The adjustment is performed by changing the rate until a safe pressure is obtained. Performing the saline test injection enabled us to check that there were no abnormalities and to carry out the injection of the contrast medium.
When an abnormality occurs, the pressure increases to an abnormally high level (Fig. 1b) , continues to rise and does not become constant (Fig. 1c) , or decreases suddenly (Fig. 1d) . The detection rate of side effects from the saline test injection was 4.4 % in the clinical cases. In these cases, examinations were completed by re-establishing an injection route or administering hypnotics. Extravasation occurred in 1.1 % of patients with side effects. Ruess et al. [8] reported that injection-induced extravasation occurred in 0.3-0.9 % of pediatric patients, a range similar to the one reported in the present study.
Confirmation of reflux from the injection route has been reported as a safety countermeasure during power injection [3, [9] [10] [11] . In some reports, the saline test injection was performed manually [2, 3, 12] . However, the rate of manual injection was not determined [2, 5] . We confirmed that there were no recognized abnormalities in a similar procedure performed at our hospital. However, extravasation still occurred during a saline test injection in 1.1 % of patients. When abnormalities during a drip injection or a manual injection cannot be confirmed, power injection may be employed. When no saline test injection is performed and extravasation is caused by contrast medium injection, repeating the examination with contrast medium injection may influence the visualization of lesions because of the injection of an unknown volume of contrast medium, or the contrast medium administration may be excessive. On the other hand, when an abnormality is observed during a saline test injection, the examination can be continued by re-establishing another injection route without influencing the visualization of lesions, because the abnormality has already been detected before injection of contrast media.
High pressure occurred in 1.5 % of our patients. High pressure indicates a high likelihood of an injection abnormality. The risk of extravasation from contrast medium injection with a power injector increased with an increase in injection pressure. Regarding the risk of extravasation, it has been reported that there was no correlation between the injection rate and the extravasation rate or comprehensive reactions [6, 10] . Amaral et al. reported that extravasation was related to a high injection rates and pressures, regardless of the location, size, or type of catheter. In addition, the risk of extravasation increased with an increase in pressure [4] . Injection of 300 mgI/mL contrast medium resulted in pressure 2.4 times higher than that generated by saline injection. Therefore, when high pressure is induced by saline injection, the risk of extravasation caused by contrast medium injection is very high.
Since the examination is frequently performed while the patient is sedated, abnormalities in contrast medium infusion are not readily noticed. Therefore, monitoring changes in injection pressure is thought to be the only method of detecting injection related abnormalities. In children, the intravascular state is uncertain, but it has been reported that injection pressure can be affected by slight differences in the angle of the needle and the fixation method. In such cases, countermeasures were taken, such as re-establishing the injection route, and an examination was performed after confirmation of the absence of abnormal pressure. This procedure may have contributed to the prevention of contrast medium injection-induced abnormalities.
Reactions to stimulation were noted in 1.9 % of our patients. When the body moves in response to stimulation during imaging, the clear images necessary for diagnosis cannot be acquired. When an abnormal reaction is detected during a saline test injection, countermeasures can be taken to prevent further abnormal reactions, and the examination can be performed after confirming the absence of reaction to injection. This prevents examination failure due to stimulation from contrast medium injection.
Conclusion
Our results suggest that contrast medium pressure can be estimated from a saline test injection; thus aiding in prediction of the risk of injection abnormality. Reactions to injections could be observed in the present study, facilitating the prevention of examination failure. Countermeasures can be taken against the cause of the reaction, and the examination can be performed after confirming the absence of a reaction to injection. Therefore, a saline test injection may be useful in pediatric contrast CT.
The safety limit for contrast medium injection pressure in pediatric patients has not been clarified. If the pressure limit can be established in the future, it may facilitate the establishment of a corresponding saline test injection pressure, leading to further improvements in safety measures.
